✦ LIBER ✦

Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: A Comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin

✍ Scribed by Carlos A De Jongh; James C Wade; Stephen C Schimpff; Kathryn A Newman; Rececca S Finley; Paula C Salvatore; Marcia R Moody; Harold C Standiford; Clarence L Fortner; Peter H Wiernik

Book ID: 115679308
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 1009 KB
Volume: 73
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(82)90935-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Empiric antibiotic therapy for suspected

Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients. A comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin: De Jongh CA, Wade JC, Schimpff SC, Newman KA, Finley RS, Salvatore PC, Moody MR, Standiford HC, Fortner CL, Wiernik PH: Am J Med 1982; 73: 89–96

📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Piperacillin or ticarcillin plus amikaci

Piperacillin or ticarcillin plus amikacin: A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients

✍ James C. Wade; Stephen C. Schimpff; Kathryn A. Newman; Clarence L. Fortner; Haro 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 897 KB

Piperacillin or ticarcillin plus amikaci

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients: Wade JC, Schimpff SC, Newman KA, Fortner CL, Standiford HC, Wiernik PH: Am J Med 1981; 71: 983–990

📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A prospective, controlled, randomized, n

A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients

✍ Simeon Metallidis; Panagiotis Kollaras; Theodoros Giannakakis; Basilis Seitanidi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Clinical outcomes in patients who receiv

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

✍ Kaplan, Muhammet Ali; Isikdogan, Abdurrahman; Koca, Doğan; Kucukoner, Mehmet; Gu 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 245 KB